These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19759252)

  • 1. Human immune proteome in experimental colonization with Staphylococcus aureus.
    Holtfreter S; Nguyen TT; Wertheim H; Steil L; Kusch H; Truong QP; Engelmann S; Hecker M; Völker U; van Belkum A; Bröker BM
    Clin Vaccine Immunol; 2009 Nov; 16(11):1607-14. PubMed ID: 19759252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis.
    Holtfreter S; Roschack K; Eichler P; Eske K; Holtfreter B; Kohler C; Engelmann S; Hecker M; Greinacher A; Broker BM
    J Infect Dis; 2006 May; 193(9):1275-8. PubMed ID: 16586365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
    Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
    J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus.
    Ghasemzadeh-Moghaddam H; van Wamel W; van Belkum A; Hamat RA; Neela VK
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):451-458. PubMed ID: 27815779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction.
    Swierstra J; Debets S; de Vogel C; Lemmens-den Toom N; Verkaik N; Ramdani-Bouguessa N; Jonkman MF; van Dijl JM; Fahal A; van Belkum A; van Wamel W
    Infect Immun; 2015 Feb; 83(2):492-501. PubMed ID: 25404029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.
    Wu Y; Liu X; Akhgar A; Li JJ; Mok H; Sellman BR; Yu L; Roskos LK; Esser MT; Ruzin A
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263109
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of antibodies by Staphylococcus aureus nasal colonization in young children.
    Verkaik NJ; Lebon A; de Vogel CP; Hooijkaas H; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; van Wamel WJ
    Clin Microbiol Infect; 2010 Aug; 16(8):1312-7. PubMed ID: 19832714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.
    Prevaes SM; van Wamel WJ; de Vogel CP; Veenhoven RH; van Gils EJ; van Belkum A; Sanders EA; Bogaert D
    Infect Immun; 2012 Jun; 80(6):2186-93. PubMed ID: 22451514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal Protein A Contributes to Persistent Colonization of Mice with Staphylococcus aureus.
    Sun Y; Emolo C; Holtfreter S; Wiles S; Kreiswirth B; Missiakas D; Schneewind O
    J Bacteriol; 2018 May; 200(9):. PubMed ID: 29440258
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory Mice Are Frequently Colonized with
    Schulz D; Grumann D; Trübe P; Pritchett-Corning K; Johnson S; Reppschläger K; Gumz J; Sundaramoorthy N; Michalik S; Berg S; van den Brandt J; Fister R; Monecke S; Uy B; Schmidt F; Bröker BM; Wiles S; Holtfreter S
    Front Cell Infect Microbiol; 2017; 7():152. PubMed ID: 28512627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reclassification of Staphylococcus aureus nasal carriage types.
    van Belkum A; Verkaik NJ; de Vogel CP; Boelens HA; Verveer J; Nouwen JL; Verbrugh HA; Wertheim HF
    J Infect Dis; 2009 Jun; 199(12):1820-6. PubMed ID: 19419332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins.
    Romero Pastrana F; Neef J; Koedijk DGAM; de Graaf D; Duipmans J; Jonkman MF; Engelmann S; van Dijl JM; Buist G
    Sci Rep; 2018 Feb; 8(1):3234. PubMed ID: 29459694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus.
    Holtfreter S; Jursa-Kulesza J; Masiuk H; Verkaik NJ; de Vogel C; Kolata J; Nowosiad M; Steil L; van Wamel W; van Belkum A; Völker U; Giedrys-Kalemba S; Bröker BM
    Eur J Clin Microbiol Infect Dis; 2011 Jun; 30(6):707-17. PubMed ID: 21509478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections.
    Adhikari RP; Ajao AO; Aman MJ; Karauzum H; Sarwar J; Lydecker AD; Johnson JK; Nguyen C; Chen WH; Roghmann MC
    J Infect Dis; 2012 Sep; 206(6):915-23. PubMed ID: 22807524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With
    Rigat F; Bartolini E; Dalsass M; Kumar N; Marchi S; Speziale P; Maione D; Chen L; Romano MR; Alegre ML; Bagnoli F; Daum RS; David MZ
    Front Immunol; 2019; 10():114. PubMed ID: 30792711
    [No Abstract]   [Full Text] [Related]  

  • 16. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus.
    Stentzel S; Teufelberger A; Nordengrün M; Kolata J; Schmidt F; van Crombruggen K; Michalik S; Kumpfmüller J; Tischer S; Schweder T; Hecker M; Engelmann S; Völker U; Krysko O; Bachert C; Bröker BM
    J Allergy Clin Immunol; 2017 Feb; 139(2):492-500.e8. PubMed ID: 27315768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers.
    Kolata J; Bode LG; Holtfreter S; Steil L; Kusch H; Holtfreter B; Albrecht D; Hecker M; Engelmann S; van Belkum A; Völker U; Bröker BM
    Proteomics; 2011 Oct; 11(19):3914-27. PubMed ID: 21805632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.
    Clarke SR; Brummell KJ; Horsburgh MJ; McDowell PW; Mohamad SA; Stapleton MR; Acevedo J; Read RC; Day NP; Peacock SJ; Mond JJ; Kokai-Kun JF; Foster SJ
    J Infect Dis; 2006 Apr; 193(8):1098-108. PubMed ID: 16544250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
    Creech CB; Johnson BG; Alsentzer AR; Hohenboken M; Edwards KM; Talbot TR
    Vaccine; 2009 Dec; 28(1):256-60. PubMed ID: 19799842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis.
    Vytvytska O; Nagy E; Blüggel M; Meyer HE; Kurzbauer R; Huber LA; Klade CS
    Proteomics; 2002 May; 2(5):580-90. PubMed ID: 11987132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.